Article info

Download PDFPDF

Cetuximab ameliorates suppressive phenotypes of myeloid antigen presenting cells in head and neck cancer patients

Authors

  • Jing Li Department of Pharmacology and Pharmaceutical Sciences, School of MedicineTsinghua University Beijing China PubMed articlesGoogle scholar articles
  • Raghvendra M. Srivastava Department of OtolaryngologyUniversity of Pittsburgh Pittsburgh PA USA PubMed articlesGoogle scholar articles
  • Abhinav Ettyreddy School of MedicineUniversity of Pittsburgh Pittsburgh PA USA PubMed articlesGoogle scholar articles
  • Robert L. Ferris Department of OtolaryngologyUniversity of Pittsburgh Pittsburgh PA USA Department of ImmunologyUniversity of Pittsburgh Pittsburgh PA USA Cancer Immunology ProgramUniversity of Pittsburgh Cancer Institute Pittsburgh PA USA Hillman Cancer Center Research Pavilion 5117 Centre Avenue, Room 2.26b 15213-1863 Pittsburgh PA USA PubMed articlesGoogle scholar articles
  1. d 412-623-0327 ferrisrl{at}upmc.edu
View Full Text

Citation

Li J, Srivastava RM, Ettyreddy A, et al
Cetuximab ameliorates suppressive phenotypes of myeloid antigen presenting cells in head and neck cancer patients

Publication history

  • Received May 21, 2015
  • Accepted October 23, 2015
  • First published November 17, 2015.
Online issue publication 
February 16, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.